Join to view full profile
801 Ostrum StBethlehem, PA 18015
Phone+1 484-526-2140
Fax+1 484-526-6055
Dr. Agarwala is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationResidency, Internal Medicine, 1992 - 1993- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1990 - 1991
Seth G.S. Medical CollegeClass of 1984
Certifications & Licensure
PA State Medical License 1993 - 2026
WI State Medical License 1993 - 1995
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification InstantPHR® CEHRT Edition, Get Real Health, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2014, 2016-2017
Clinical Trials
- High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma Start of enrollment: 1999 Mar 25
- FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma Start of enrollment: 2005 Oct 04
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
Publications & Presentations
PubMed
- 7 citationsAccuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients.Ning Liao, Cheukfai Li, William J Gradishar, V Suzanne Klimberg, Joshua A Roshal
JCO Clinical Cancer Informatics. 2025-06-01 - 12 citationsSystemic Therapy for Melanoma: ASCO Guideline Update Q and A.Vernon K Sondak, Michael B Atkins, Hans Messersmith, Anthony Provenzano, Rahul Seth
JCO Oncology Practice. 2024-02-01 - 167 citationsSystemic Therapy for Melanoma: ASCO Guideline Update.Rahul Seth, Sanjiv S Agarwala, Hans Messersmith, Krishna C Alluri, Paolo A Ascierto
Journal of Clinical Oncology. 2023-10-20
Press Mentions
Groundbreaking Trial by Indian American Researcher Sanjiv Agarwala Sees Cancerous Tumors ‘Flake Off’July 3rd, 2019
Cancerous Tumors Flake off After Injection of Exotic ‘Rose Bengal’ in Groundbreaking St. Luke’s TrialJune 27th, 2019
Optimizing Adjuvant Strategies Extends RFS in High-Risk MelanomaMarch 11th, 2019
Grant Support
- Ph1 Stdy Epidermal Grwth FCT REC Tyrosine Kinase INH Combo W/DocetaxelNational Center For Research Resources2005
- PH II UCN-01 Metastatic MelanomaNational Center For Research Resources2005
- PHI Dose Escal. Study Eval Safety Of AlbuleukinNational Center For Research Resources2004
- Ph3, Mc, Ol, Surv/Safety Study Of Head/Neck CarcinomaNational Center For Research Resources2004
- Ph1 Study EGFR Tyrosine Kinase Inhibitor W/ DocetaxelNational Center For Research Resources2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
